Medical Weight Reduction Programme

A 6–12 month physician-led weight reduction programme at ALPHALABS, structured for men and women who have not achieved lasting results through diet and exercise alone. The programme uses a medically supported appetite regulation and metabolic optimisation protocol, with regular physician check-ups tracking hormonal, metabolic and clinical markers throughout. Average body-weight reduction is up to 15% over the programme duration. The full programme is priced at 89,990 Kč (current promotional rate 79,990 Kč).

ALPHALABS's medical weight reduction programme is designed for individuals whose weight is driven by hormonal imbalance, metabolic dysfunction or appetite dysregulation — factors that conventional dietary advice does not adequately address. The programme is particularly suited to men experiencing androgen-related metabolic changes, and women navigating weight gain associated with menopause, PCOS or insulin resistance. The programme begins with a comprehensive physician assessment. This intake appointment covers full medical history, a blood panel assessing fasting glucose, HbA1c, insulin sensitivity, hormonal markers, thyroid function and lipid profile, plus physical measurements including BMI, waist circumference and body composition. The physician uses these findings to rule out contraindications, identify metabolic drivers of weight gain and design an individualised protocol. The therapeutic core of the programme is an appetite regulation and satiety support regimen — language consistent with GLP-1 receptor agonist therapy (such as semaglutide or analogous agents), though the specific medication is not named on the clinic's website. The 'simple home regime' structure the clinic describes involves a consistent daily or weekly self-administration protocol, supported by physician-guided nutritional adjustments. Clients are not placed on a generic meal plan but coached on sustainable eating habits compatible with their lifestyle. Physician appointments recur throughout the 6–12-month programme at intervals determined by progress and the monitoring schedule. At each check-up, the physician reviews weight change, body composition, metabolic markers (glucose, insulin, lipids) and wellbeing, adjusting the therapeutic dose or nutritional plan if necessary. The clinic targets an average body-weight reduction of up to 15% over the full programme duration — a figure consistent with published clinical data for GLP-1 agonist protocols. The programme is open to men and women. Specific candidacy considerations include BMI ≥27 with metabolic comorbidities, previous failure of lifestyle-only interventions, or weight gain attributable to hormonal or metabolic changes. Active cardiovascular disease, pregnancy and certain endocrine conditions are assessed individually at intake. The all-inclusive programme fee covers therapeutic products, monitoring appointments and physician consultation for the full duration.